Fig. 4.
Mitigative effect of T7E21RHD5 treatment on the enterogenic infection caused by IR. (A) Determination of LPS levels in mouse serum. Results are presented as the means ± SD. ***P < 0.001. (B) Incidence of bacteremia in TAI mice in the presence and absence of peptide treatment. (C) Alleviation of T7E21RHD5 on IR-induced upregulations of IL-1β and IL-6 in mouse ileum. Results are shown as the means ± SD. **P < 0.01; ***P < 0.001.
